Matthew J. During

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

Michael G. Kaplitt, Andrew Feigin, Chengke Tang et al. · The Lancet · 2007 · 1.1K citations

Medicine, Neurology, Neuroscience +17

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

Michael G. Kaplitt, Paola Leone, R. Jude Samulski et al. · Nature Genetics · 1994 · 1K citations

Life Sciences, Molecular Biology, Neuroscience +17

VEGF links hippocampal activity with neurogenesis, learning and memory

Lei Cao, Xiangyang Jiao, David S. Zuzga et al. · Nature Genetics · 2004 · 851 citations

Medicine, Neurobiology, Neuroscience +12

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

Matthew J. During, Lei Cao, David S. Zuzga et al. · Nature Medicine · 2003 · 844 citations

Life Sciences, Neurobiology, Neuroscience +12

Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial

Robert E. MacLaren, Markus Groppe, Alun R. Barnard et al. · The Lancet · 2014 · 781 citations · Full text

Medicine, Molecular Medicine, Ophthalmology +12